ARS Pharmaceuticals Inc is a biotechnology company that develops innovative treatments for autoimmune diseases and severe allergic reactions. It operates primarily in North America, focusing on the development and commercialisation of inhalation products for severe respiratory conditions and major health issues.
ARS Pharmaceuticals operates in the biopharmaceutical sector. The company's products are designed to be safe and effective, needle-free and easy for patients and caregivers to administer.
Keep up to date on the latest share price changes by adding SPRY stock to your eToro watchlist.